The protective role of SGLT2 inhibitors on aortic aneurysm mediated by oxidative stress and inflammation in type 2 diabetes mellitus
Abstract Background Sodium-glucose transport protein 2 inhibitors (SGLT2i) have been widely used to treat patients with type 2 diabetes mellitus (T2DM) and have demonstrated protective effects against certain cardiovascular diseases. However, no clinical research has been conducted to explore the re...
Saved in:
Main Authors: | Rujie Zheng, Wenjuan Song, Jie Lu, Mingyue Yuan, Xiaotong Sun, Chengzhi Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12933-025-02600-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The SGLT-2 Inhibitors and their Role in the Treatment of Heart Failure - A Review of Literature
by: Silvia Ciraolo, et al.
Published: (2025-02-01) -
A rare case of Thoracic Aortic Aneurysm repair post Heart Transplantation
by: Helena Garcia Betinardi Bernardi, et al.
Published: (2025-02-01) -
Impact of Hospitalization on Continuation of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Comorbidities in Patients with Type 2 Diabetes
by: Bethany Murphy, et al.
Published: (2025-01-01) -
Does the type of aortic pathology affect periprocedural outcomes in patients undergoing thoracic endovascular aortic repair?
by: Serdar Badem, et al.
Published: (2024-03-01) -
The impact of aneurysm volume on midterm Post-EVAR outcomes
by: Mehmet Ali Turkcu, et al.
Published: (2024-03-01)